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Edited by Francesc PosasAbstract CtBP corepressor proteins potentiate the activity of
many metazoan transcriptional repressors. These proteins are
homologous to prokaryotic D-2-hydroxyacid dehydrogenases,
possessing an NAD/NADH binding fold and conserved active
site residues. When expressed in Drosophila, a catalytic site mu-
tant retains biological activity, however, we ﬁnd that an NAD
binding mutant lacks biological activity. The NAD mutant, sim-
ilar to a dimerization mutant, is expressed at low levels, indicat-
ing that binding of NAD/NADH may aﬀect CtBP stability.
These data support the idea that the ancestral dehydrogenase
activity is not required for CtBP function, and NAD binding
may play a regulatory, rather than catalytic, role.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Transcriptional repression1. Introduction
The C-terminal binding protein (CtBP) corepressor was
identiﬁed as a modulator of E1A viral oncoprotein activity
and as a mediator of transcriptional repression in Drosophila
and vertebrate cells [1–3]. CtBP binds to transcription factors
via its N terminus, which interacts with PXDLS motifs in
target proteins, allowing its recruitment to promoters [4,5].
The protein also interacts with histone deacetylases, methyl
transferases, and demethylases, suggesting that a complex
of chromatin remodeling agents mediates its repressive activ-
ity [6].
Structurally, CtBPs bear striking resemblances to D-2-
hydroxyacid dehydrogenases, including an NAD(H) binding
Rossman fold and a putative active site that contains con-
served histidine, glutamate, and arginine residues [7]. Verte-
brate CtBP1 and CtBP2 proteins contain a less-well
conserved domain at the C-terminus that is a target of phos-*Corresponding author. Address: Department of Biochemistry and
Molecular Biology, Michigan State University, East Lansing, MI
48824, USA. Fax: +1 517 353 9334.
E-mail address: arnosti@msu.edu (D.N. Arnosti).
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.10.011phorylation and SUMOylation; this domain is suggested to
be unstructured [8]. The single CtBP gene in Drosophila en-
codes two isoforms: CtBPL, which contains a similar C-termi-
nal region, and CtBPS, which lacks it. The expression of the
two isoforms is developmentally regulated and the C-terminal
coding region is evolutionarily conserved [9].
CtBP has been shown to bind NAD and NADH, which af-
fects the conformation of the protein and its aﬃnity for E1A.
The binding of the dinucleotide has also been reported to alter
its oligomerization properties [10–12]. A diﬀerential aﬃnity for
NADH over NAD has been suggested to allow this factor to
respond to changes in cellular redox status in vivo, and treat-
ment of cells with agents that aﬀect NAD/NADH ratios aﬀect
gene expression in a CtBP dependent manner. Other reports
do not ﬁnd diﬀerences in eﬀects of the oxidized and reduced
dinucleotides on CtBP in vitro, however [10–12].
Consistent with their structural similarity to dehydrogen-
ases, CtBP proteins can catalyze an NAD-dependent pyru-
vate-to-lactate dehydrogenase reaction in vitro that requires
the conserved catalytic histidine residue [11,12]. It is not clear,
however, whether this putative enzymatic activity or NAD
binding are important for CtBP function in vivo. Repression
assays comparing the activities of mutant forms of CtBP have
not produced completely consistent results. Three general
types of cell-based assays have tested the ability of CtBP to
mediate transcriptional repression, those using endogenous
promoters (some coupled to reporter genes), those with artiﬁ-
cial constructs that are regulated by CtBPs (e.g. Gal4-E1A fu-
sions), and assays using promoters bound by Gal4-CtBP
chimeras. In most cases, forms of CtBP lacking catalytic site
residues (including the conserved histidine) are functional,
although one report found that such mutations blocked E1A
association in vitro and abolished repression in vivo [11]. In
three cases, mutations that disrupt residues of the nucleotide
binding pocket blocked transcriptional repression activity,
while another report did not ﬁnd any eﬀect of such mutations
[11,13–15].
Apart from these cell-based assays, the signiﬁcance of the
NAD binding and putative catalytic activity of CtBP remains
to be determined in a developmental context, where these pro-
teins are known to play critical roles. A number of studies have
indicated that CtBP proteins are located in the cytoplasm and
likely carry out functions unrelated to transcription, such as
regulation of Golgi function, and synaptic transmission in ret-
inal cells [16].blished by Elsevier B.V. All rights reserved.
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2.1. Transgene construction
CtBP cDNA fragments (Accession Nos. AY060646, dCtBPL;
AB011840, dCtBPS) were ampliﬁed by PCR to introduce KpnI and
XbaI sites at 5 0 and 3 0 ends, respectively, and modiﬁed to introduce
a double C-terminal FLAG epitope tag [17]. For tissue-speciﬁc expres-
sion, the cDNAs were inserted into a modiﬁed pUAST vector contain-
ing KpnI and XbaI sites downstream of a consensus Drosophila
Kozak sequence (DA 683 5 0-GATCACCCGGGACCAAAATGGG-
TAC-3 0and DA 684 5 0-CCATTTTGGTCCCGGGT-3 0) [18]. NAD
and CAT mutants were described previously [17]. In the DIM mu-
tant, arginine codons (R141A, R142A, R163A and R171A) were mod-
iﬁed in dCtBPL. For ubiquitous expression, the basal hsp70 promoter
and 5X UAS sites were removed from pUAST by digestion with SphI
and KpnI, and an oligonucleotide was introduced containing SphI,
AscI, Kozak, and KpnI sites (DA 885 5 0-CACCGGCGCGCCACCA-
AAATGGGTAC-3 0; DA 886 5 0-CCATTTTGGTGGCGCGCCGGT-
GCATG-30). An 8 kp CtBP upstream promoter region (CG8837323-
8845092) was inserted as two 4 kbp SphI–SphI and SphI–AscI frag-
ments using DA 926 (5 0-GTGCATGCGAAATGGTTAGCCAGCG-
TGGTG-30), DA 927 (5 0-CGGGCGCGCCTTGAAATCGAGAAT-
CCTGCAATGG-3 0), DA 924 (5 0-CTGCATGCATACCATAATTC-
TTGCAGTTTGCC-3 0) and DA 925 (5 0-CGGCATGCAGCTTTCT-
GTTTCATGCATATGCAC-3 0).
2.2. Immunoprecipitations and western blot analysis
Embryos (0–12 h) were collected from transgenic lines expressing
FLAG-tagged CtBP proteins, resuspended in lysis buﬀer (150 mM
NaCl, 50 mM HEPES, pH 7.9, 10% glycerol, 0.1 mM EDTA with
Complete mini-EDTA free protease inhibitor cocktail, Roche) and
sonicated. Soluble lysates (20 mg total protein) were immunoprecipi-
tated overnight at 4 C with 25 ll of anti-M2 crosslinked to protein
G beads. Immunoprecipitation with mouse monoclonal IgG andRRRR
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Fig. 1. Expression of wild-type CtBP or CAT mutant proteins leads to deve
in Drosophila. Point mutations in dimerization interface (RRRR to AAAA),
indicated by arrowheads. (B) Drosophila wing and eye showing phenotypic c
imaginal discs. Misexpression of wild-type or CAT mutant induces rough
control of wing-speciﬁc en-Gal4 and eye-speciﬁc GMR-Gal4 transgenic driver
NAD or DIM proteins (b, d). Three independent lines were assessed foranti-M2 with non-transgenic embryo extracts was performed in paral-
lel as negative controls. Beads were washed thrice in lysis buﬀer and
eluted in 40 ll of Laemmli sample buﬀer. Immunoprecipitates or ex-
tracts from adults, prepared by pestling and sonication, were run on
10% SDS–PAGE gels and analyzed by western blotting using anti-
CtBP (rabbit polyclonal, 1:10000) and Immuno-Blot PVDF mem-
brane (Bio-Rad) [19]. Antibody incubation was performed in TBST
(20 mM Tris–HCl, pH 7.5, 120 mM NaCl, 0.1% Tween-20) with 5%
non-fat dry milk. Mouse monoclonal antibodies used were M2 anti-
FLAG (Sigma) (1:10000) and anti-tubulin (1:6000, Iowa Hybridoma
Bank). Blots were developed using HRP-conjugated secondary anti-
bodies (Pierce) and SuperSignal West Pico chemiluminiscent sub-
strate (Pierce). Western blot quantitation shown in Fig. 2 is
representative for more than three independent experiments. For
immunoprecipitation experiments shown in Fig. 3, independent immu-
noprecipitations were conducted from separate biological preparations
2–3 times, with identical results.
2.3. P-element transformation and antibody staining of imaginal discs
Drosophila germline transformation with P element vectors was per-
formed as described previously [17]. Imaginal discs dissected from
third instar larvae were ﬁxed in antibody staining buﬀer (10 mM potas-
sium phosphate, pH 6.8, 15 mM NaCl, 45 mM KCl and 2 mMMgCl2)
and 37% formaldehyde on ice for 45 min. For detection of FLAG-
tagged proteins, anti-M2 was used at a concentration of 1:1500, and
developed using a universal secondary antibody conjugated to HRP
(1:250). Discs were mounted in 80% glycerol and the expression pat-
tern was visualized using an Elite PK-62000 Universal Vectastain
ABC kit (Vector Laboratories Inc., Manufacturer’s protocol).
2.4. Recombinant CtBP proteins and gel ﬁltration chromatography
For protein expression, CtBP cDNAs were cloned into a modiﬁed
pET15b expression vector using Kpn I and Not I restriction sites.
The CAT mutant cDNA contained 2 FLAG-tags at the C-terminus,FF
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lopmental defects in Drosophila. (A) Structure of transgenes expressed
NAD-binding pocket (G · G to A · A), and catalytic pocket (H–Q) are
onsequences of expression of CtBP protein in developing wing and eye
eye phenotype and posterior wing blisters when expressed under the
lines (a, c). No mutant phenotypes were observed for lines expressing
each transgene, and similar results were observed.
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transformed into Escherichia coli strain BL21 (DE3). Twenty-ﬁve mil-
liliters of log phase bacterial cultures were induced with 0.8 mM IPTG
overnight at 16 C. The cells were collected, resuspended in buﬀer
(50 mM HEPES pH 7.9, 150 mM NaCl, 10% glycerol, 10 mM imidaz-
ole with Roche cocktail protease inhibitor tablet and 12.5% b-mercap-
toethanol), sonicated and centrifuged to separate soluble supernatant
fraction. 0.1% Triton X was added to supernatant before incubation
with Ni2+-NTA beads (Sigma) at 4 C for 3 h. The beads were washed
thrice in the same buﬀer with 20 mM imidazole and eluted with
250 mM imidazole. Approximately 10 lg of puriﬁed protein was frac-
tionated on a Superdex 200 10/30 size exclusion column (Amersham)
equilibrated with buﬀer (150 mM NaCl, 50 mM HEPES pH 7.9,
0.1 mM EDTA,10% glycerol). 0.5 ml fractions were collected at a ﬂow
rate of 0.5 ml/min. Pools of fractions were resolved on SDS–PAGE
gels and analyzed by western blotting using M2 anti-FLAG antibody.
Size markers (MW-GF-1000, Sigma) were separated under similar con-
ditions for calibration. The migration of the NAD mutant as a dimer
was conﬁrmed by two independent chromatographic separations.Table 1
Quantitation of misexpression phenotypes Flies with ectopic expression of
developmental defects in wing or eye
Transgene Eye phenotypes
Rough eyes (%) # Lines tested n
CtBPL w.t. 79–87 4 758
CAT- 84-91 3 272
NAD- 0 3 580
DIM- 0 6 618
None 0 – 210
No aberrant wing or eye phenotypes were noted in ﬂies expressing NAD and
of detected mutant phenotypes for lines tested. 3–6 independent lines per tra
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Fig. 2. Relative expression levels of CtBP proteins in transgenic Drosophil
proteins. Total extracts from single adults were analyzed by western blotting u
expressed comparably, while expression of the NAD or DIM proteins wa
transgenic lines. The bottom panel shows b-tubulin as a loading control. (B) T
antibody to measure expression of CtBP proteins under the control of the GM
or DIM proteins in individual imaginal discs.3. Results
3.1. Expression and biological activity of wild-type and
dehydrogenase domain mutants in vivo
To investigate the functional relevance of conserved residues
within CtBP, we generated mutant forms for expression in
transgenic Drosophila. cDNAs for the ‘‘long’’ form of CtBP
containing the C-terminal extension [9] were generated that
carried mutations for conserved glycine residues critical for
NAD binding (NAD), or the histidine residue that is required
for dehydrogenase activity in CtBP and related dehydrogenase
enzymes (CAT), or four arginine residues predicted to lie at
the dimer interface (DIM) (Fig. 1A) [5,11]. Using the pUAS
system, these cDNAs were expressed in the developing eye disc
using a GMR-Gal4 driver or in the wing disc using the en-Gal4
driver. Ectopic expression of the wild-type CtBPL protein orwild-type, CAT, NAD and DIM CtBP proteins were scored for
Wing phenotypes
Wing defects (%) # Lines tested n
8–30 4 490
20–42 4 958
0 3 724
0 4 436
0 – 124
DIM mutant proteins. The percentages give the range of frequencies
nsgene were assayed.
IB :anti-M2
4
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a. (A) Western blot of extracts from adult ﬂies overexpressing CtBP
sing anti-Flag M2 antibody. Wild-type CtBPL and CAT
 proteins were
s considerably lower. Similar expression levels were noted for multiple
hird instar imaginal eye discs were stained with anti-FLAG epitope M2
R-Gal4 driver. Low levels of expression were observed for the NAD
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5244 P. Mani-Telang et al. / FEBS Letters 581 (2007) 5241–5246the CATmutant induced wing blisters or rough eyes in a high
percentage of oﬀspring (Fig. 1, Table 1). In contrast, expres-
sion of the NAD or DIM mutants did not result in an obvi-
ous phenotype in this assay (Table 1). The developmental
defects observed here may be due to a number of regulatory
changes; CtBP participates in control of a number of genes
in the eye and wing, and misexpression of other corepressors
such as Rbf1 has been observed to induce similar phenotypes
[20,21].
The misexpressed transgenes carry a C-terminal FLAG tag
that permits detection of the recombinant protein. To compare
relative expression levels of the diﬀerent transgenes, protein ex-
tracts were prepared from individual adult ﬂies expressing one
form of CtBP. Wild-type and CAT proteins were found to be
present at comparable levels, while the steady-state levels of
the NAD or DIM proteins were considerably reduced
(Fig. 2A). Larval protein levels were assessed by immunostain-
ing of developing eye discs, with similar low levels noted for
the NAD or DIM proteins (Fig. 2B). These diﬀerences in
protein levels were not a result of position eﬀects of the trans-
gene insertion sites, because steady-state levels for each con-
struct were very similar for multiple independent transgenic
lines, and for constructs driven by diﬀerent promoters (data
not shown).an
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Fig. 3. Immunoprecipitation of endogenous CtBP proteins with
transgenic CtBP proteins showing formation of heteromeric com-
plexes. Endogenous and overexpressed CtBP proteins were detected in
crude extracts and immunoprecipitates with polyclonal anti-CtBP
antibody. (A) lane 1, CAT mutant protein and endogenous CtBPL
and CtBPS proteins in crude extract (epitope-tagged protein migrates
slower than endogenous 50 kDa form); lane 2, CtBP proteins in non-
transgenic ﬂy extract; lane 3, immunoprecipitate from transgenic ﬂy
extract using anti-FLAG epitope M2 antibody, showing enrichment of
CAT protein, as well as endogenous CtBPL and CtBPS. Lanes 4 and 5
control precipitations with no antibody or non-speciﬁc mouse IgG. (B)
Immunoprecipitation of FLAG-tagged wild-type CtBPL. Lane 1,
extract containing recombinant CtBPL; lane 2, control M2 immuno-
precipitate of non-transgenic extract; lane 3, immunoprecipitate of
extract containing FLAG-tagged wild-type CtBPL; lane 4, control
precipitations with no antibody. (C) wild-type CtBPS. Immunopre-
cipitations were as shown in (B). A non-speciﬁc band is marked with
an asterisk.3.2. Dimerization of CtBP isoforms
The similar phenotypes and levels of expression of the wild-
type CtBPL and the CAT
 mutants suggests that the mutant
protein retains biological activity despite absence of a residue
critical for dehydrogenase activity. Similar results have been
noted in most cell-based assays, which have been usually con-
ducted in the presence of the wild-type endogenous CtBP.
CtBP is a dimeric protein, therefore we considered that the
CAT mutant might be capable of forming heterodimers with
endogenous CtBP. To test this idea, we prepared lysates from
Drosophila expressing the CAT mutant protein, as well as
lines expressing the wild-type CtBPL and CtBPS isoforms.
Immunoprecipitations were carried out with anti-FLAG anti-
body speciﬁc for the recombinant protein, and Western blots
were developed using anti-CtBP antibody to detect both
endogenous and recombinant proteins. As shown in Fig. 3A,
endogenous CtBP isoforms speciﬁcally co-immunoprecipitate
with the CAT mutant protein, consistent with the formation
of heterodimers between these proteins. In light of these re-
sults, it is possible that biologically active CAT/wild-type het-
erodimers may mask the loss of dehydrogenase activity in one
subunit, although this would not explain our misexpression
phenotype, as discussed below. Immunoprecipitations also
showed that ectopically expressed wild-type CtBPL and CtBPS
speciﬁcally coprecipitated with both forms of endogenous
CtBP proteins, indicating that in Drosophila, CtBP dimers
may possess either one or two C-terminal extension domains,
or entirely lack this domain that is suggested to be of regula-
tory signiﬁcance (Fig. 3B and C) [9].3.3. Physical studies of mutant proteins
The low steady-state levels of the DIM mutant suggest that
a defect in CtBP dimerization may destabilize the protein. Pre-
vious work showed that in vitro dimerization of the wild-type
protein is stimulated by the presence of NAD(H), thus it
seemed possible that the NAD mutation may similarlyprevent dimerization by blocking association of NAD(H),
leading to destabilization [12,22]. To test this idea, we ex-
pressed each form of the protein in E. coli and measured the
migration proﬁles using size exclusion chromatography. Com-
paring elution proﬁles of wild-type CtBP to those of molecular
weight standards, the peak fraction for CtBPL was close to
150 kDa, suggesting that this protein is already in a dimeric
state, consistent with the migration pattern observed for re-
combinant vertebrate CtBP (Fig. 4). This pattern did not
change with addition of NAD (not shown), probably because
the protein is already bound to dinucleotide acquired during
1 2 3 4 5 6 7 8 9 10 11 12
CtBPL
CAT-
NAD-
DIM-
66 KDa150 KDa200 KDa 34 KDa
Fig. 4. Chromatographic properties of puriﬁed CtBP proteins indicate that NAD mutant forms similar size complexes as wild-type and CAT
proteins. Similar amounts (approximately 10 lg) of each Flag-tagged puriﬁed CtBP proteins were individually subjected to size exclusion
chromatography. Wild-type, CAT-, and NAD-mutant proteins eluted with similar proﬁles, consistent with dimer formation (150 kDa). DIM-
mutant proteins eluted in later fractions, consistent with monomers. Pooled aliquots of fractions were analyzed by Western blot analysis using
monoclonal anti-Flag M2 antibody. Elution proﬁle of molecular size standards fractionated under similar conditions are indicated by arrows.
P. Mani-Telang et al. / FEBS Letters 581 (2007) 5241–5246 5245protein expression [5]. The CAT mutant protein had a similar
proﬁle, with the peak fractions overlapping with those for the
wild-type. Signiﬁcantly, the DIM mutant had a markedly dis-
placed peak, with most of the protein eluting in later fractions,
consistent with the monomeric form. This result correlates
with the inability of a similar mutant form of vertebrate CtBP
protein to bind to immobilized GST-CtBP [11]. Importantly,
the NAD mutant protein eluted with a proﬁle very similar
to that of the wild-type and CAT mutant, and not similar
to the DIM mutant (Fig. 4). (Similar amounts of each recom-
binant protein were applied to the column, thus these mutant
forms are of similar abundance as the wild-type protein, unlike
the situation in Fig. 2A) These data strongly suggest that dis-
rupting the NAD binding cleft does not prevent dimerization,
thus the low expression levels of this form of the protein may
reﬂect an altered conformation, rather than an inability to
form dimers.4. Discussion
The conservation of NAD-binding and catalytic residues in
CtBP raised the possibility that this transcriptional cofactor
may possess a conserved enzymatic activity, perhaps similar
to the NAD-dependent deacetylation function of Sir2 proteins.
However, no such in vitro deacetylase activity has been identi-
ﬁed, rather, a weak dehydrogenase activity, and a putative acyl
transferase or acyl-CoA binding activity, the latter of which
has been recently suggested to correspond to an associated
or contaminating activity, not to CtBP itself [16,23]. Our data
in Drosophila, and other studies in vertebrate cells, strongly
suggest that residues of the catalytic site are not required for
in vivo function. One documented CAT mutant that is im-
paired for in vivo activity involved more extensive mutations
to four residues within the putative catalytic center, which re-
sulted in a protein unable to bind to a target E1A protein [11].
However, a mutation to the single conserved histidine, as in the
CAT mutant tested here, is suﬃcient to abolish in vitro dehy-drogenase activity [12]. We determined that the CAT mutant
is capable of dimerizing with wild-type CtBP, but if the mutant
protein would only be functional as a heterodimer, it does not
seem likely that we would be able to achieve levels suﬃcient to
generate an overexpression phenotype, because heterodimers
would increase the overall levels of CtBP by at most twofold.
We have found that low-levels of misexpression of CtBP pro-
teins do not produce phenotypes (P. Mani-Telang, unpub-
lished). Furthermore, a similar CAT mutant protein tested
in CtBP cells, where heterodimerization is not a possibility,
had wild-type activity [14].
On the other hand, several studies indicate that NAD bind-
ing appears to be an important feature of CtBP protein. Muta-
tions that block NAD interaction prevent CtBP from
associating with E1A and repressing transcription [11]. We
found that even when the protein is tethered to a target gene
by the Gal4 DNA binding domain, NAD binding residues
were critical for transcriptional repression in embryos [17].
The previously observed NAD-stimulated CtBP dimer forma-
tion provided a potential explanation of these results, in that
loss of NAD binding might prevent dimers from forming.
However, we explicitly test this idea in Fig. 4, and we do not
see a change in dimerization with the NAD mutant, which
carries mutations in glycines known to be critical for NAD
binding by CtBP and related proteins. A more likely explana-
tion is that NAD, which binds the Rossman fold in a ‘‘closed’’
conformation, and aﬀects CtBP conformation in vitro, permits
the protein to make critical contacts with essential transcrip-
tional factors or cofactors. The question arises whether this
proposed structural role for NAD in assembly of CtBP com-
plexes serves a regulatory role as well. Treatments aﬀecting
NAD/NADH ratios in vertebrate cells lead to loss of CtBP
association with target genes and the HIC transcription factor,
thus CtBP may function as a redox sensitive switch, in which
NAD(H) binding plays an important role [24]. Further exam-
ination of the function of CtBP proteins in a developmental
setting will provide insight on the physiological signiﬁcance
of these activities.
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